Spots Global Cancer Trial Database for recurrent extrahepatic bile duct cancer

Every month we try and update this database with for recurrent extrahepatic bile duct cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder	NCT00084942	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	Roswell Park Cancer Institute
Interleukin-12 in Treating Patients With Cancer in the Abdomen	NCT00003046	Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc...	Recombinant Int...	18 Years -	M.D. Anderson Cancer Center
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer	NCT00274885	Cancer	oxaliplatin management of t...	18 Years -	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Cancer in the Abdomen	NCT00003046	Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc...	Recombinant Int...	18 Years -	M.D. Anderson Cancer Center
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer	NCT00107536	Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer	NCT02088775	Adult Primary H... Advanced Adult ... Metastatic Extr... Recurrent Adult... Recurrent Extra... Stage D Adult P... Unspecified Adu...	PET scan CT Scan hepatic artery ...	18 Years -	Fox Chase Cancer Center
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer	NCT00073905	Extrahepatic Bi... Gallbladder Can... Liver Cancer Pain	capecitabine pl...	18 Years - 80 Years	Swiss Group for Clinical Cancer Research
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer	NCT00003427	Anal Cancer Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine...	irinotecan hydr... oxaliplatin	18 Years -	Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer	NCT00009893	Extrahepatic Bi... Gallbladder Can... Liver Cancer	fluorouracil gemcitabine hyd... leucovorin calc...	18 Years - 120 Years	Alliance for Clinical Trials in Oncology
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	NCT00004895	Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine...	octreotide acet...	18 Years -	Northwestern University
Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder	NCT00085410	Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Gastrointestina... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	bortezomib	18 Years -	National Cancer Institute (NCI)
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum	NCT00005860	Cancer	floxuridine leucovorin calc... oxaliplatin	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers	NCT01229111	Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Periampullary A... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	cediranib malea... oxaliplatin leucovorin calc... fluorouracil	18 Years -	National Cancer Institute (NCI)
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer	NCT00266097	Extrahepatic Bi... Gallbladder Can... Pancreatic Canc...	erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin	18 Years -	UNC Lineberger Comprehensive Cancer Center
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer	NCT00544193	Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera...	18 Years - 70 Years	City of Hope Medical Center
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
Irinotecan and Capecitabine in Treating Patients With Solid Tumors	NCT00003867	Cancer	capecitabine irinotecan hydr...	18 Years - 120 Years	Montefiore Medical Center
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer	NCT00266097	Extrahepatic Bi... Gallbladder Can... Pancreatic Canc...	erlotinib hydro... gemcitabine hyd... oxaliplatin radiation thera... gemcitabine hyd... Oxaliplatin	18 Years -	UNC Lineberger Comprehensive Cancer Center
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors	NCT00356889	Cholangiocarcin... Cholangiocarcin... Gastrointestina... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... bevacizumab	18 Years -	National Cancer Institute (NCI)
Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery	NCT00101036	Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer	NCT00486356	Extrahepatic Bi... Gallbladder Can... Gastric Cancer Liver Cancer Unspecified Adu...	capecitabine carboplatin epirubicin hydr... microarray anal... polymorphism an... pharmacological...	18 Years - 120 Years	University of Nebraska
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery	NCT00513539	Extrahepatic Bi... Gallbladder Can...	porfimer sodium biliary stentin...	18 Years -	University College, London
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery	NCT00478140	Adenocarcinoma ... Adenocarcinoma ... Malignant Neopl... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	trastuzumab laboratory biom...	18 Years -	National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer	NCT00087191	Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga...	EF5 motexafin lutet... pharmacological...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer	NCT00009893	Extrahepatic Bi... Gallbladder Can... Liver Cancer	fluorouracil gemcitabine hyd... leucovorin calc...	18 Years - 120 Years	Alliance for Clinical Trials in Oncology
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer	NCT00033462	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer	NCT02088775	Adult Primary H... Advanced Adult ... Metastatic Extr... Recurrent Adult... Recurrent Extra... Stage D Adult P... Unspecified Adu...	PET scan CT Scan hepatic artery ...	18 Years -	Fox Chase Cancer Center
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer	NCT00397384	Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Carcinoma of th... Gastrointestina... Metastatic Gast... Metastatic Squa... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Colon... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Pancr... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Colon ... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Pancre... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Tongue Cancer Unresectable Ex... Unresectable Ga...	cetuximab erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer	NCT00073905	Extrahepatic Bi... Gallbladder Can... Liver Cancer Pain	capecitabine pl...	18 Years - 80 Years	Swiss Group for Clinical Cancer Research
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer	NCT00019474	Extrahepatic Bi... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine...	filgrastim recombinant int... fluorouracil hydroxyurea	18 Years - 120 Years	Montefiore Medical Center
Irinotecan and Capecitabine in Treating Patients With Solid Tumors	NCT00003867	Cancer	capecitabine irinotecan hydr...	18 Years - 120 Years	Montefiore Medical Center
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors	NCT00356889	Cholangiocarcin... Cholangiocarcin... Gastrointestina... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... bevacizumab	18 Years -	National Cancer Institute (NCI)
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen	NCT00016380	Cancer	dexamethasone ondansetron quality-of-life...	16 Years - 120 Years	Canadian Cancer Trials Group
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer	NCT00658593	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine gemcitabine hyd... quality-of-life...	18 Years - 120 Years	Canadian Cancer Trials Group
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer	NCT00658593	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine gemcitabine hyd... quality-of-life...	18 Years - 120 Years	Canadian Cancer Trials Group
Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery	NCT01859182	Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Localized Unres... Metastatic Extr... Recurrent Adult... Recurrent Extra... Stage II Gallbl... Stage IIIA Gall... Stage IIIB Gall... Stage IVA Gallb... Stage IVB Gallb... Unresectable Ex...	selumetinib Akt inhibitor M... laboratory biom... pharmacogenomic... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer	NCT00003557	Extrahepatic Bi... Gallbladder Can... Liver Cancer	dolastatin 10	18 Years -	University of Chicago
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors	NCT00262769	Extrahepatic Bi... Gallbladder Can...	cisplatin gemcitabine hyd...	16 Years -	University College, London
Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery	NCT00101036	Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery	NCT00004895	Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine...	octreotide acet...	18 Years -	Northwestern University
Interleukin-12 in Treating Patients With Cancer in the Abdomen	NCT00003046	Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc...	Recombinant Int...	18 Years -	M.D. Anderson Cancer Center
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer	NCT00107536	Adult Primary H... Advanced Adult ... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	lapatinib ditos... laboratory biom...	18 Years -	National Cancer Institute (NCI)
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
Gene Therapy in Treating Patients With Cancer	NCT00004178	Cancer	therapeutic aut...	18 Years -	Roger Williams Medical Center
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor	NCT00021047	Esophageal Canc... Extrahepatic Bi... Gastric Cancer Head and Neck C... Liver Cancer Unspecified Adu...	capecitabine carboplatin epirubicin hydr...	18 Years -	National Institutes of Health Clinical Center (CC)
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas	NCT00003923	Extrahepatic Bi... Gallbladder Can... Liver Cancer Pancreatic Canc...	porfimer sodium	18 Years -	Memorial Sloan Kettering Cancer Center
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions	NCT00066404	Cancer	recombinant ade...	18 Years - 120 Years	Abramson Cancer Center at Penn Medicine
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer	NCT00544193	Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera...	18 Years - 70 Years	City of Hope Medical Center
Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder	NCT00085410	Adenocarcinoma ... Adenocarcinoma ... Advanced Adult ... Gastrointestina... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	bortezomib	18 Years -	National Cancer Institute (NCI)
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer	NCT00033462	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen	NCT00016380	Cancer	dexamethasone ondansetron quality-of-life...	16 Years - 120 Years	Canadian Cancer Trials Group
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions	NCT00066404	Cancer	recombinant ade...	18 Years - 120 Years	Abramson Cancer Center at Penn Medicine
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer	NCT00096083	Cancer	isolated perfus... melphalan	16 Years -	Delcath Systems Inc.
Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery	NCT00478140	Adenocarcinoma ... Adenocarcinoma ... Malignant Neopl... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	trastuzumab laboratory biom...	18 Years -	National Cancer Institute (NCI)
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer	NCT00030511	Extrahepatic Bi... Liver Cancer	fluorouracil conventional su... radiation thera...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction	NCT00004910	Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Gastrointestina... Pancreatic Canc... Quality of Life Small Intestine...	bowel obstructi... quality-of-life...	18 Years -	Northwestern University
Biological Therapy in Treating Patients With Metastatic Cancer	NCT00004604	Breast Cancer Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Lung Cancer Metastatic Canc... Ovarian Cancer Pancreatic Canc... Testicular Germ...	CEA RNA-pulsed ...	18 Years -	Duke University
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: